Action is the latest following Baldwin’s investigation into the extremely high prices these companies charge for inhalers ...

Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...

AstraZeneca and Daiichi Sankyo shared the pooled analysis behind the refiling of their TROP2 antibody-drug conjugate (ADC) ...

Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...

The blow fill seal technology market is expected to grow from its estimated USD 3,107.8 million in 2024 to USD 5,258.5 million in 2034. Between 2024 and 2034, sales are expected to increase at a ...

The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are high worldwide, contributing ...

GSK has made the decision to withdraw Jesduvroq (daprodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, from the US market.